Form 4 for INSM INSMED Inc
Accepted 2025-06-12 00:00:00 ET · period of report 2025-06-10 · accession 0001628280-25-030969 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-12 | 2025-06-10+ | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale+OE | $92.09 | -137.5K | 153.5K | -47% | -$12.66M |
| DM | 2025-06-12 | 2025-06-10+ | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $15.06 | +108.3K | 156.9K | +223% | +$1.63M |
| DM | 2025-06-12 | 2025-06-10+ | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $0.00 | -108.3K | 87.3K | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-11 | S | D | 500 | $96.02 | 89,407 | D | — | — | (F7) This is the weighted average sales price representing 500 shares sold at prices ranging from $96.00 to $96.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2025-06-11 | S | D | 34,500 | $95.49 | 89,907 | D | — | — | (F6) This is the weighted average sales price representing 34,500 shares sold at prices ranging from $95.00 to $95.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2025-06-11 | S | D | 10,781 | $93.48 | 124,407 | D | — | — | (F5) This is the weighted average sales price representing 10,781 shares sold at prices ranging from $93.20 to $93.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Common | Common Stock | 2025-06-11 | S | D | 18,319 | $92.73 | 135,188 | D | — | — | (F4) This is the weighted average sales price representing 18,319 shares sold at prices ranging from $92.20 to $93.19 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 5 | Common | Common Stock | 2025-06-11 | M | A | 70,000 | $13.91 | 188,579 | D | — | — | |
| 6 | Common | Common Stock | 2025-06-10 | S | D | 38,300 | $88.64 | 118,579 | D | — | — | |
| 7 | Common | Common Stock | 2025-06-10 | M | A | 38,300 | $17.16 | 156,879 | D | — | — | |
| 8 | Common | Common Stock | 2025-06-11 | S | D | 35,072 | $91.68 | 153,507 | D | — | — | (F3) This is the weighted average sales price representing 35,072 shares sold at prices ranging from $91.18 to $92.17 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 9 | Derivative | Stock Option (right to buy) | 2025-06-10 | M | D | 38,300 | $0.00 | 0 | D | $17.16 · — to 2027-05-17 | 38,300 Common Stock | (F8) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 10 | Derivative | Stock Option (right to buy) | 2025-06-11 | M | D | 70,000 | $0.00 | 87,290 | D | $13.91 · — to 2029-01-03 | 70,000 Common Stock | (F8) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |